Evonik Industries AG
F:EVK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Evonik Industries AG
F:EVK
|
DE |
Evonik Industries AG
Evonik Industries AG is a German specialty chemicals company. It makes ingredients and materials that other companies use to improve their own products, such as additives for coatings and plastics, feed amino acids for animal nutrition, and specialty materials for things like adhesives, cosmetics, and medical products. Its customers are mainly industrial manufacturers, agriculture and animal feed producers, and consumer-goods companies that need consistent, high-performance chemical inputs. The company sells these products through long-term supply relationships and technical service, rather than one-off consumer sales. It makes money by producing and selling specialty chemicals that are often tied to specific customer formulations or production processes, which can create recurring demand and switching costs. In many cases, Evonik is a supplier that sits in the middle of the value chain, helping its customers improve performance, efficiency, or product quality. What makes Evonik different is its focus on specialized chemistry instead of basic bulk chemicals. That means it often competes on product know-how, reliability, and close customer support, not just on price. This gives the business a role as a behind-the-scenes partner to industrial and consumer brands that need tailored chemical ingredients.
Evonik Industries AG is a German specialty chemicals company. It makes ingredients and materials that other companies use to improve their own products, such as additives for coatings and plastics, feed amino acids for animal nutrition, and specialty materials for things like adhesives, cosmetics, and medical products. Its customers are mainly industrial manufacturers, agriculture and animal feed producers, and consumer-goods companies that need consistent, high-performance chemical inputs.
The company sells these products through long-term supply relationships and technical service, rather than one-off consumer sales. It makes money by producing and selling specialty chemicals that are often tied to specific customer formulations or production processes, which can create recurring demand and switching costs. In many cases, Evonik is a supplier that sits in the middle of the value chain, helping its customers improve performance, efficiency, or product quality.
What makes Evonik different is its focus on specialized chemistry instead of basic bulk chemicals. That means it often competes on product know-how, reliability, and close customer support, not just on price. This gives the business a role as a behind-the-scenes partner to industrial and consumer brands that need tailored chemical ingredients.
Q1 beat: Evonik reported adjusted EBITDA of EUR 475 million in Q1, slightly above the company’s expectations, helped by self-help measures and a much stronger March after a weak January and February.
Q2 outlook: Management guided to at least EUR 550 million of adjusted EBITDA in Q2, saying April demand was strong but warning that higher input costs, supply chain risks, and Singapore-related volume limits could cap upside.
Full-year unchanged: The company confirmed its full-year 2026 adjusted EBITDA outlook of EUR 1.7 billion to EUR 2 billion, while stressing that the second half looks more uncertain.
Prebuying: Management said much of the recent volume strength looks like customer prebuying rather than a real improvement in end demand, though some market-share gains are also showing through in select businesses.
Methionine strength: Methionine remains a major tailwind, with Evonik saying 2026 is shaping up to be its third straight year of better-than-expected performance and that Q2 should be strong despite the force majeure in Singapore.
Cash flow: Free cash flow was EUR 183 million in Q1, which management said was strong and supported by customer payments and other timing effects, even though earnings were weaker year on year.
